,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #eeca ,,in ,,the ,,house ,,of ,,representatives ,april #ag1 #bjah,mr4 ,buchanan 7for himself and ,mrs4 ,murphy of ,florida7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committees on ,ways and ,means1 the ,budget1 ,veterans' ,affairs1 ,oversight and ,government ,reform1 and the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to provide for a comprehensive1 multifaceted approach to preventing and treating opioid addiction4 #a4 ,short title2 table of contents 7a7 ,short title ,this ,act may be cited as the ,opioid ,emergency ,response ,act4 7b7 ,table of contents ,the table of contents for this ,act is as follows3 ,sec4 #a4 ,short title2 table of contents4 ,sec4 #b4 ,alternatives to opioids prescribing4 ,sec4 #c4 ,opioids and ,,stop ,pain ,initiative4 ,sec4 #d4 ,veteran over-medication prevention4 ,sec4 #e4 ,amendment relating to the account for the ,state response to the opioid abuse crisis4 ,sec4 #f4 ,mental health access improvement4 ,sec4 #g4 ,synthetics ,trafficking and ,overdose ,prevention4 ,sec4 #h4 ,stop the ,importation and ,trafficking of ,synthetic ,analogues4 #b4 ,alternatives to opioids prescribing 7a7 ,establishment ,beginning not later than one year after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services 7in this ,act referred to as the ,secretary7 shall carry out a #e-year demonstration project under which payment shall be made under the hospital outpatient prospective payment system under part ,b of title ,,xviii of the ,social ,security ,act 7#db ,u4,s4,c4 #acie;j et seq47 to participating hospitals for items and services furnished as alternatives to opioid medications to individuals enrolled under such part to treat conditions designated under subsection 7c77#a7 for purposes of evaluating the benefits of using1 instead of opioid medications1 such alternatives to treat in emergency departments such symptoms and conditions4 7b7 ,emergency departments 7#a7 ,selection ,the ,secretary shall select from hospitals with emergency departments voluntarily submitting applications under paragraph 7#d71 not fewer than #cj hospitals with emergency departments1 and not more than #ej hospitals with emergency departments1 for participation in the demonstration project4 7#b7 ,diversity ,in selecting hospitals with emergency departments1 the ,secretary shall ensure such hospitals and emergency departments are diverse in geography and size4 7#c7 ,voluntary participation ,participation in the demonstration project under this section shall be on a voluntary basis4 7#d7 ,applications 7,a7 ,in general ,to participate in the demonstration project1 a hospital with an emergency department shall submit to the ,secretary an application at such time1 in such manner1 and containing such information 7in addition to the written commitment described in subparagraph 7,b77 as specified by the ,secretary4 ,the ,secretary shall take such measures as is necessary to make available such application form to potential participants no later than #ahj days after the date of the enactment of this ,act4 7,b7 ,information required ,each application submitted by a hospital under subparagraph 7,a7 shall include a binding written commitment to participate in the demonstration project for the duration of the project signed by the ,chief ,executive ,officer of the hospital1 the physician medical director of the emergency department of the hospital1 the nursing director of the emergency department of the hospital1 and the pharmacy director of the emergency department of the hospital4 7c7 ,elements of demonstration project ,under the demonstration project1 the following shall apply3 7#a7 ,the ,secretary shall designate no fewer than five conditions or sets of symptoms that will be monitored during the demonstration project4 7#b7 ,the performance during each year of the demonstration project1 with respect to such conditions designated under paragraph 7#a71 of all emergency departments of hospitals participating in the demonstration project will be measured against the performance of such emergency departments during a base year1 which shall represent the most recent set of full year data available before the first date of the demonstration project4 7#c7 ,the ,secretary shall provide hospitals participating in the demonstration project with a description of clearly defined treatments that are considered alternatives to opioids to be applied for purposes of subsection 7a74 7d7 ,incentive payment ,under the demonstration project1 the ,secretary shall create a payment structure under which hospitals participating in the demonstration project that increase the use of alternatives to opioids and decrease the use of opioids may receive a shared savings bonus in addition to what would otherwise be made for items and services furnished under subsection 7a74 ,the amount of such shared savings shall be based on the difference between readmission rates for individuals treated with an alternative to opioids at the emergency department of the participating hospital and the average rate of readmissions for individuals treated with opioids and discharged from a representative group of emergency departments of hospitals not participating in the demonstration project in the same region as the participating hospital over a period of five years4 7e7 ,clarification ,nothing under this section shall prevent a health care provider from prescribing an opioid if an opioid is a medically necessary treatment4 7f7 ,reports to ,congress 7#a7 ,initial report ,not later than #ahj days after the date of the enactment of this ,act1 the ,secretary shall submit to ,congress a report that includes-- 7,a7 the application form described in subsection 7b77#d77;,a7 that is to be made available to potential participants2 and 7,b7 a progress report with respect to designating the conditions under subsection 7c77#a7 and establishing the description of clearly defined treatments described in subsection 7c77#c74 7#b7 ,periodic demonstration reports ,beginning after the first year of the demonstration project and annually thereafter for each year of the demonstration project and not later than one year after the completion of the demonstration1 the ,secretary shall submit to ,congress a report that includes the following data for each hospital participating under the demonstration project3 7,a7 ,with respect to each condition or set of symptom designated under subsection 7c77#a71 the number of individuals treated4 7,b7 ,with respect to each such condition1 the number of individuals treated only with an alternative to opioids4 7,c7 ,with respect to each such condition1 the number of individuals treated first with an alternative to opioids1 followed by an opioid in the same visit4 7,d7 ,with respect to each such condition1 the number of individuals treated only with an opioid4 7,e7 ,with respect to each individual described in subparagraph 7,a7 treated for such a condition or set of symptoms1 whether or not the individual involved returned to the emergency department of the hospital or an emergency department of a different hospital for the same condition or symptoms4 7,f7 ,the difference in cost between treating an individual with an alternative to opioid versus an opioid4 7,g7 ,any additional information the ,secretary determines necessary4 #c4 ,opioids and ,,stop ,pain ,initiative 7a7 ,establishment ,there is established an ,opioids and ,,stop ,pain ,initiative1 to be administered by the ,director of the ,national ,institutes of ,health1 in coordination with other agencies1 as appropriate1 which shall include efforts to support research on the following3 7#a7 ,section #ajh of the ,comprehensive ,addiction and ,recovery ,act of #bjaf 7#db ,u4,s4,c4 #bhdq-#a71 known as the ,,stop ,pain ,act1 which directs the ,national ,institutes of ,health to intensify and coordinate fundamental1 translational1 and clinical research with respect to-- 7,a7 the understanding of pain2 7,b7 the discovery and development of therapies for chronic pain2 and 7,c7 the development of alternatives to opioids for effective pain treatments4 7#b7 ,developing improved options and evidence for medication-assisted treatment4 7#c7 ,developing improved options and evidence for opioid overdose reversal treatments4 7#d7 ,the ,federal ,pain ,research ,strategy1 including research that focuses on-- 7,a7 novel drugs1 non-addictive1 and non-pharmacological treatments for pain2 7,b7 screening tools and outcome measure for assessments across the continuum of pain2 7,c7 national registries1 datasets1 and research networks2 7,d7 effective models of care delivery for pain management2 and 7,e7 precision medicine methodology to prevent and treat pain4 7#e7 ,the components of the ,department of ,health and ,human ,services five-point strategy to address the opioid crisis that states3 ,providing support for cutting edge research on pain and addiction4 7#f7 ,the pain therapy screening program established under subsection 7c74 7#g7 ,other elements that the ,secretary of ,health and ,human ,services may designate1 in consultation with the ,director of the ,national ,institutes of ,health4 7b7 ,funding for the ,opioids and ,,stop ,pain ,initiative 7#a7 ,in general ,there is authorized to be appropriated1 and there is appropriated1 #ejj1jjj1jjj1 to be used during the #e-;fiscal-year period beginning in the fiscal year in which such funds are appropriated1 to the ,national ,institutes of ,health ,innovation ,account to be used to administer the ,opioids and ,,stop ,pain ,initiative established under subsection 7a74 7#b7 ,emergency spending 7,a7 ,in general ,amounts appropriated under paragraph 7#a7 are designated as an emergency requirement pursuant to section #d7;g7 of the ,statutory ,pay-,as-,you-,go ,act of #bjaj 7#b ,u4,s4,c4 #icc7;g774 7,b7 ,designation in the senate ,in the ,senate1 amounts appropriated under subsection 7a7 are designated as an emergency requirement pursuant to section #djc7;a7 of ,s4 ,con4 ,res4 #ac 7#aaath ,congress71 the concurrent resolution on the budget for fiscal year #bjaj4 7c7 ,pain ,therapy ,screening ,program 7#a7 ,in general ,the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary7 shall carry out through the ,national ,institutes of ,health a program to be known as the ,pain ,therapy ,screening ,program that focuses on the development of pain therapeutics4 7#b7 ,grants ,the ,secretary shall award grants under the program under paragraph 7#a7 to eligible public and private nonprofit entities to support the development of new pre-clinical models for pain disorders1 and the application of these models in drug1 device1 or other therapy screening4 7#c7 ,model ,the program under this section shall be modeled after the ,epilepsy ,therapy ,screening ,program carried out by the ,national ,institute of ,neurological ,disorders and ,stroke4 7#d7 ,fees ,the ,secretary of ,health and ,human ,services may assess reasonable fees on private pharmaceutical or medical device industry entities that utilize the program under this section to screen proprietary molecular compounds and devices4 ,such fees shall be paid to the ,foundation for the ,national ,institutes of ,health and transferred to the ,,nih ,innovation ,account to be used for the ,opioids and ,,stop ,pain ,initiative established under subsection 7a74 7#e7 ,funding ,the ,director of the ,national ,institutes of ,health shall determine the amount1 and allocate1 funds from the amount appropriated under subsection 7b71 to carry out this section4 7d7 ,funding provisions 7#a7 ,supplement not supplant ,amounts appropriated in this section 7including the amendments made by this section7 shall be used to supplement1 not supplant1 current funding for pain and opioid research at the ,national ,institutes of ,health4 7#b7 ,acceptance of donations ,notwithstanding section #acdb of title #ca1 ,united ,states ,code1 the ,secretary of ,health and ,human ,services may accept donations 7including from the pharmaceutical and medical device industries7 to be used to assist in carrying out programs and activities under this section 7and the amendments made by this section74 ,such donations shall be paid to the ,foundation for the ,national ,institutes of ,health and transferred to the ,,nih ,innovation ,account to be used for the ,opioids and ,,stop ,pain ,initiative established under subsection 7a74 7#c7 ,inclusion of contribution amounts in basic research for purposes of research credit 7,a7 ,in general ,paragraph 7#f7 of section #da7;e7 of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following new subparagraph3 7,e7 ,opioids and ,,stop ,pain ,initiative ,the ,national ,institutes of ,health1 if the payment is made in support of the ,opioids and ,,stop ,pain ,initiative1 as established by the ,opioids and ,,stop ,pain ,initiative ,act4 4 7,b7 ,effective date ,the amendments made by this subsection shall apply to taxable years beginning after the date of the enactment of this ,act4 7e7 ,authority ,notwithstanding any other provision of the law1 the ,director of the ,national ,institutes of ,health may use funds available under subsection 7b7 to enter into transactions 7other than contracts1 cooperative agreements1 or grants7 to carry out research identified pursuant to the ,opioids and ,,stop ,pain ,initiative established under subsection 7a74 7f7 ,reports 7#a7 ,annual reports ,not later than ,october #a of each of fiscal years #bjai through #bjbf1 the ,director of the ,national ,institutes of ,health shall submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions and the ,committee on ,appropriations of the ,senate and the ,committee on ,energy and ,commerce and the ,committee on ,appropriations of the ,house of ,representatives1 a report that includes-- 7,a7 the amount obligated or expended in the fiscal year prior to the fiscal year in which the report is being submitted for each program or activity described in this section 7or an amendment made by this section72 7,b7 a description of all such programs or activities carried out using funds provided under this section 7or amendments72 and 7,c7 a description of how such programs or activities are advancing public health1 including the impact on treating pain and addressing opioid misuse in the ,united ,states4 7#b7 ,additional reports ,at the request of the ,committee on ,health1 ,education1 ,labor1 and ,pensions or the ,committee on ,appropriations of the ,senate1 or the ,committee on ,energy and ,commerce or the ,committee on ,appropriations of the ,house of ,representatives1 the ,director of the ,national ,institutes of ,health shall provide to the relevant committee an update in the form of testimony and additional reports concerning the allocation of funding under this section 7or the amendments made by this section7 or the description of the programs and activities carried out with such funding4 #d4 ,veteran over-medication prevention 7a7 ,review required 7#a7 ,in general ,not later than #ij days after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs shall seek to enter into an agreement with the ,national ,academies of ,sciences1 ,engineering1 and ,medicine under which the ,national ,academies shall conduct a review of the deaths of all covered veterans who died by suicide during the five-year period ending on the date of the enactment of this ,act1 regardless of whether information relating to such deaths has been reported by the ,centers for ,disease ,control and ,prevention4 7#b7 ,elements ,the review required by paragraph 7#a7 shall include the following3 7,a7 ,the total number of covered veterans who died by suicide during the five-year period ending on the date of the enactment of this ,act4 7,b7 ,the total number of covered veterans who died by a violent death during such five-year period4 7,c7 ,the total number of covered veterans who died by an accidental death during such five-year period4 7,d7 ,a description of each covered veteran described in subparagraphs 7,a7 through 7,c71 including age1 gender1 race1 and ethnicity4 7,e7 ,a comprehensive list of prescribed medications and legal or illegal substances as annotated on toxicology reports of covered veterans described in subparagraphs 7,a7 through 7,c71 specifically listing any medications that carried a black box warning1 were prescribed for off-label use1 were psychotropic1 or carried warnings that included suicidal ideation4 7,f7 ,a summary of medical diagnoses by physicians of the ,department of ,veterans ,affairs or physicians providing services to covered veterans through programs of the ,department that led to the prescribing of medications referred to in subparagraph 7,e7 in cases of post-traumatic stress disorder1 traumatic brain injury1 military sexual trauma1 and other anxiety and depressive disorders4 7,g7 ,the number of instances in which a covered veteran described in subparagraph 7,a71 7,b71 or 7,c7 was concurrently on multiple medications prescribed by physicians of the ,department or physicians providing services to veterans through programs of the ,department to treat post-traumatic stress disorder1 traumatic brain injury1 military sexual trauma1 other anxiety and depressive disorders1 or instances of comorbidity4 7,h7 ,the number of covered veterans described in subparagraphs 7,a7 through 7,c7 who were not taking any medication prescribed by a physician of the ,department or a physician providing services to veterans through a program of the ,department4 7,i7 ,with respect to the treatment of post-traumatic stress disorder1 traumatic brain injury1 military sexual trauma1 or other anxiety and depressive disorders1 the percentage of covered veterans described in subparagraphs 7,a7 through 7,c7 who received a non-medication first-line treatment compared to the percentage of such veterans who received medication only4 7,j7 ,with respect to the treatment of covered veterans described in subparagraphs 7,a7 through 7,c7 for post-traumatic stress disorder1 traumatic brain injury1 military sexual trauma1 or other anxiety and depressive disorders1 the number of instances in which a non-medication first-line treatment 7such as cognitive behavioral therapy7 was attempted and determined to be ineffective for such a veteran1 which subsequently led to the prescribing of a medication referred to in subparagraph 7,e74 7,k7 ,a description and example of how the ,department determines and continually updates the clinical practice guidelines governing the prescribing of medications4 7,l7 ,an analysis of the use by the ,department1 including protocols or practices at medical facilities of the ,department1 of systematically measuring pain scores during clinical encounters under the ,pain as the #eth ,vital ,sign ,toolkit of the ,department and an evaluation of the relationship between the use of such measurements and the number of veterans concurrently on multiple medications prescribed by physicians of the ,department4 7,m7 ,a description of the efforts of the ,department to maintain appropriate staffing levels for mental health professionals1 such as mental health counselors1 marriage and family therapists1 and other appropriate counselors1 including-- 7i7 a description of any impediments to carry out the education1 training1 and hiring of mental health counselors and marriage and family therapists under section #gcjb7;a7 of title #ch1 ,united ,states ,code1 and strategies for addressing those impediments2 7ii7 a description of the objectives1 goals1 and timing of the ,department with respect to increasing the representation of such counselors and therapists in the behavioral health workforce of the ,department1 including-- 7,i7 a review of eligibility criteria for such counselors and therapists and a comparison of such criteria to that of other behavioral health professions in the ,department2 and 7,,ii7 an assessment of the participation of such counselors and therapists in the mental health professionals trainee program of the ,department and any impediments to such participation2 7iii7 an assessment of the development by the ,department of hiring guidelines for mental health counselors1 marriage and family therapists1 and other appropriate counselors2 7iv7 a description of how the ,department-- 7,i7 identifies gaps in the supply of mental health professionals2 and 7,,ii7 determines successful staffing ratios for mental health professionals of the ,department2 7v7 a description of actions taken by the ,secretary1 in consultation with the ,director of the ,office of ,personnel ,management1 to create an occupational series for mental health counselors and marriage and family therapists of the ,department and a timeline for the creation of such an occupational series2 and 7vi7 a description of actions taken by the ,secretary to ensure that the national1 regional1 and local professional standards boards for mental health counselors and marriage and family therapists are comprised of only mental health counselors and marriage and family therapists and that the liaison from the ,department to such boards is a mental health counselor or marriage and family therapist4 7,n7 ,the percentage of covered veterans described in subparagraphs 7,a7 through 7,c7 with combat experience or trauma related to combat experience 7including military sexual trauma1 traumatic brain injury1 and post-traumatic stress74 7,o7 ,an identification of the medical facilities of the ,department with markedly high prescription rates and suicide rates for veterans receiving treatment at those facilities4 7,p7 ,an analysis1 by ,state1 of programs of the ,department that collaborate with ,state ,medicaid agencies and the ,centers for ,medicare and ,medicaid ,services1 including the following3 7i7 ,an analysis of the sharing of prescription and behavioral health data for veterans4 7ii7 ,an analysis of whether ,department staff check with ,state prescription drug monitoring programs before prescribing medications to veterans4 7iii7 ,a description of the procedures of the ,department for coordinating with prescribers outside of the ,department to ensure that veterans are not overprescribed4 7iv7 ,a description of actions that the ,department takes when a veteran is determined to be overprescribed4 7,q7 ,an analysis of the collaboration of medical centers of the ,department with medical examiners' offices or local jurisdictions to determine veteran mortality and cause of death4 7,r7 ,an identification and determination of a best practice model to collect and share veteran death certificate data between the ,department of ,veterans ,affairs1 the ,department of ,defense1 ,states1 and tribal entities4 7,s7 ,a description of how data relating to death certificates of veterans is collected1 determined1 and reported by the ,department of ,veterans ,affairs4 7,t7 ,an assessment of any patterns apparent to the ,national ,academies of ,sciences1 ,engineering1 and ,medicine based on the review conducted under paragraph 7#a74 7,u7 ,such recommendations for further action that would improve the safety and well-being of veterans as the ,national ,academies of ,sciences1 ,engineering1 and ,medicine determine appropriate4 7#c7 ,compilation of data 7,a7 ,form of compilation ,the ,secretary of ,veterans ,affairs shall ensure that data compiled under paragraph 7#b7 is compiled in a manner that allows it to be analyzed across all data fields for purposes of informing and updating clinical practice guidelines of the ,department of ,veterans ,affairs4 7,b7 ,compilation of data regarding covered veterans ,in compiling data under paragraph 7#b7 regarding covered veterans described in subparagraphs 7,a7 through 7,c7 of such paragraph1 data regarding veterans described in each such subparagraph shall be compiled separately and disaggregated by year4 7#d7 ,completion of review and report ,the agreement entered into under paragraph 7#a7 shall require that the ,national ,academies of ,sciences1 ,engineering1 and ,medicine complete the review under such paragraph and submit to the ,secretary of ,veterans ,affairs a report containing the results of the review not later than #ahj days after entering into the agreement4 7b7 ,report ,not later than #cj days after the completion by the ,national ,academies of ,sciences1 ,engineering1 and ,medicine of the review required under subsection 7a71 the ,secretary of ,veterans ,affairs shall-- 7#a7 submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report on the results of the review2 and 7#b7 make such report publicly available4 7c7 ,definitions ,in this section3 7#a7 ,the term black box warning means a warning displayed on the label of a prescription drug that is designed to call attention to the serious or life-threatening risk of the prescription drug4 7#b7 ,the term covered veteran means a veteran who received hospital care or medical services furnished by the ,department of ,veterans ,affairs during the five-year period preceding the death of the veteran4 7#c7 ,the term first-line treatment means a potential intervention that has been evaluated and assigned a high score within clinical practice guidelines4 7#d7 ,the term ,state means each of the ,states1 territories1 and possessions of the ,united ,states1 the ,district of ,columbia1 and the ,commonwealth of ,puerto ,rico4 #e4 ,amendment relating to the account for the ,state response to the opioid abuse crisis ,section #ajjc of the #bast ,century ,cures ,act 7,public ,law #aad-bee2 #db ,u4,s4,c4 #bij;ee-#c note7 is amended in subsection 7b77#c71 by adding at the end the following new subparagraph3 7,c7 ,appropriations after fiscal year #bjah ,there is authorized to be appropriated1 and there is appropriated1 out of any monies in the ,treasury not otherwise appropriated1 to the ,account ,for the ,state ,response to the ,opioid ,abuse ,crisis #ejj1jjj1jjj for each of fiscal years #bjai through #bjbc4 4 #f4 ,mental health access improvement 7a7 ,coverage of ,services 7#a7 ,in general ,section #ahfa7s77#b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7s77#b77 is amended-- 7,a7 in subparagraph 7,,ff71 by striking and after the semicolon at the end2 7,b7 in subparagraph 7,,gg71 by inserting and after the semicolon at the end2 and 7,c7 by adding at the end the following new subparagraph3 7,,hh7 marriage and family therapist services 7as defined in subsection 7jjj77#a77 and mental health counselor services 7as defined in subsection 7jjj77#c772 4 7#b7 ,definitions ,section #ahfa of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7 is amended by adding at the end the following new subsection3 7jjj7 ,marriage and ,family ,therapist ,services2 ,marriage and ,family ,therapist2 ,mental ,health ,counselor ,services2 ,mental ,health ,counselor 7#a7 ,the term marriage and family therapist services means services performed by a marriage and family therapist 7as defined in paragraph 7#b77 for the diagnosis and treatment of mental illnesses1 which the marriage and family therapist is legally authorized to perform under ,state law 7or the ,state regulatory mechanism provided by ,state law7 of the ,state in which such services are performed1 as would otherwise be covered if furnished by a physician or as an incident to a physician's professional service1 but only if no facility or other provider charges or is paid any amounts with respect to the furnishing of such services4 7#b7 ,the term marriage and family therapist means an individual who-- 7,a7 possesses a master's or doctoral degree which qualifies for licensure or certification as a marriage and family therapist pursuant to ,state law2 7,b7 after obtaining such degree has performed at least #b years of clinical supervised experience in marriage and family therapy2 and 7,c7 in the case of an individual performing services in a ,state that provides for licensure or certification of marriage and family therapists1 is licensed or certified as a marriage and family therapist in such ,state4 7#c7 ,the term mental health counselor services means services performed by a mental health counselor 7as defined in paragraph 7#d77 for the diagnosis and treatment of mental illnesses which the mental health counselor is legally authorized to perform under ,state law 7or the ,state regulatory mechanism provided by the ,state law7 of the ,state in which such services are performed1 as would otherwise be covered if furnished by a physician or as incident to a physician's professional service1 but only if no facility or other provider charges or is paid any amounts with respect to the furnishing of such services4 7#d7 ,the term mental health counselor means an individual who-- 7,a7 possesses a master's or doctor's degree in mental health counseling or a related field2 7,b7 after obtaining such a degree has performed at least #b years of supervised mental health counselor practice2 and 7,c7 in the case of an individual performing services in a ,state that provides for licensure or certification of mental health counselors or professional counselors1 is licensed or certified as a mental health counselor or professional counselor in such ,state4 4 7#c7 ,provision for payment under part ,b ,section #ahcb7;a77#b77;,b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciek7a77#b77;,b77 is amended by adding at the end the following new clause3 7v7 marriage and family therapist services 7as defined in section #ahfa7;jjj77#a77 and mental health counselor services 7as defined in section #ahfa7;jjj77#c772 4 7#d7 ,amount of payment ,section #ahcc7;a77#a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciel7a77#a77 is amended-- 7,a7 by striking and 7,,bb7 and inserting 7,,bb72 and 7,b7 by inserting before the semicolon at the end the following3 1 and 7,,cc7 with respect to marriage and family therapist services and mental health counselor services under section #ahfa7s77#b77;,,hh71 the amounts paid shall be #hj percent of the lesser of the actual charge for the services or #ge percent of the amount determined for payment of a psychologist under subparagraph 7,l74 7#e7 ,exclusion of marriage and family therapist services and mental health counselor services from skilled nursing facility prospective payment system ,section #ahhh7;e77#b77;,a77ii7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acieyy7e77#b77;,a77ii77 is amended by inserting marriage and family therapist services 7as defined in section #ahfa7;jjj77#a771 mental health counselor services 7as defined in section #ahfa7;jjj77#c771 after qualified psychologist services14 7#f7 ,inclusion of marriage and family therapists and mental health counselors as practitioners for assignment of claims ,section #ahdb7;b77#ah77;,c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acieu7b77#ah77;,c77 is amended by adding at the end the following new clauses3 7vii7 ,a marriage and family therapist 7as defined in section #ahfa7;jjj77#b774 7viii7 ,a mental health counselor 7as defined in section #ahfa7;jjj77#d774 4 7b7 ,coverage of certain mental health services provided in certain settings 7#a7 ,rural health clinics and federally qualified health centers ,section #ahfa7;aa77#a77;,b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7aa77#a77;,b77 is amended by striking or by a clinical social worker 7as defined in subsection 7hh77#a77 and inserting 1 by a clinical social worker 7as defined in subsection 7hh77#a771 by a marriage and family therapist 7as defined in subsection 7jjj77#b771 or by a mental health counselor 7as defined in subsection 7jjj77#d774 7#b7 ,hospice programs ,section #ahfa7;dd77#b77;,b77i77,,iii7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7dd77#b77;,b77i77,,iii77 is amended by inserting 1 marriage and family therapist1 or mental health counselor after social worker4 7c7 ,authorization of marriage and family therapists and mental health counselors ,to develop discharge plans for post-,hospital services ,section #ahfa7;ee77#b77;,g7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7ee77#b77;,g77 is amended by inserting 1 including a marriage and family therapist and a mental health counselor who meets qualification standards established by the ,secretary before the period at the end4 7d7 ,effective date ,the amendments made by this section shall apply with respect to services furnished on or after ,january #a1 #bjai4 #g4 ,synthetics ,trafficking and ,overdose ,prevention 7a7 ,formal entry requirements--postal service as consignee ,subparagraph 7,b7 of section #dhd7;a77#b7 of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #adhd7;a77#b77;,b77 is amended to read as follows3 7,b7 7i7 ,when an entry of merchandise is made under this section1 the required documentation or information shall be filed or electronically transmitted-- 7,i7 by the owner or purchaser of the merchandise2 or 7,,ii7 when appropriately designated by the owner1 purchaser1 or consignee of the merchandise1 by a person holding a valid license under section #fda4 7ii7 ,the ,postmaster ,general shall be deemed the consignee for merchandise1 as defined by section #dih7;c71 imported through the mail1 and the ,postmaster ,general shall1 at the ,postmaster ,general's sole expense1 designate a person holding a valid license under section #fda to file the required documentation or information or ensure that the owner or purchaser of the merchandise or a person holding a valid license under section #fda that is designated by the owner or purchaser files the required documentation or information4 7iii7 ,when a consignee declares on entry that he or she is the owner or purchaser of merchandise1 ,u4,s4 ,customs and ,border ,protection may1 without liability1 accept the declaration4 7iv7 ,for the purposes of this ,act1 the importer of record must be one of the parties who is eligible to file the documentation or information required by this section4 4 7b7 ,informal entries ,section #dih of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #adih7 is amended by adding at the end the following3 7c7 ,application to postal shipments 7#a7 ,definitions ,in this subsection3 7,a7 ,document ,the term document means a piece of written1 drawn1 printed1 or digital information1 excluding objects of merchandise1 that-- 7i7 is conveyed in an envelope that is less than or equal to #afe millimeters in width1 #bde millimeters in length1 and #e millimeters in depth2 and 7ii7 weighs #ajj grams or less when conveyed4 7,b7 ,merchandise ,the term merchandise has the same meaning as that term is defined in section #dja but does not include a document4 7#b7 ,requirement ,notwithstanding any other provision of law1 for merchandise meeting the requirements of subsection 7a71 the ,postmaster ,general shall comply with the entry requirements of section #dhd4 7#c7 ,regulations ,any regulation issued pursuant to this subsection shall apply identical entry procedures for merchandise imported through the mail as are applied for merchandise imported via a private carrier4 4 7c7 ,de minimis shipments ,section #cba of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #acba7 is amended by adding at the end the following3 7c7 7#a7 ,for imported articles that qualify for the administrative exemption under subsection 7a77#b7 and that arrive at international mail facilities in the ,united ,states1 the ,postmaster ,general shall be deemed the consignee for such articles that are considered merchandise1 as the term is defined in section #dih7;c74 7#b7 ,in addition to the parties that are authorized to comply with the entry requirements of sections #dih and #dhd1 the ,postmaster ,general1 as a consignee1 may1 using reasonable care1 enter such merchandise that qualifies for the administrative exemption under subsection 7a77#b74 4 7d7 ,customs fees 7#a7 ,in general ,paragraph 7#f7 of section #acjca7;a7 of the ,consolidated ,omnibus ,budget ,reconciliation ,act of #aihe 7#ai ,u4,s4,c4 #eh;c7a77#f77 is amended to read as follows3 7#f7 7,a7 ,for the arrival of shipments of merchandise 7as the term is defined in section #dih7;c7 of the ,trade ,act of #aicj7 or any other item that is valued at #b1jjj or less 7or such higher amount as the ,secretary of the ,treasury may set by regulation pursuant to section #dih of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #adih7 and subject to adjustment under subsection 7l77 arriving at an international mail facility3 7i7 #a per individual airway bill or bill of lading 7subject to adjustment under subsection 7l772 or 7ii7 if such merchandise is formally entered1 the fee provided for in paragraph 7#i71 if applicable4 7,b7 ,notwithstanding section #dea of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #adea71 the payment required by subparagraph 7,a7 shall be the only payment required for reimbursement of ,u4,s4 ,customs and ,border ,protection in connection with the processing of an individual airway bill or bill of lading in accordance with such subparagraph and for providing services at international mail facilities1 except that ,u4,s4 ,customs and ,border ,protection may require such facilities to cover expenses of the agency for adequate office space1 equipment1 furnishings1 supplies1 and security4 7,c7 ,the payment required by subparagraphs 7,a7 and 7,b7 shall be paid on a quarterly basis by the ,postmaster ,general in accordance with regulations prescribed by the ,secretary of the ,treasury4 ,the payments shall be allocated as follows3 7i7 #ej percent of the amount of payments received in this paragraph shall1 in accordance with section #ebd of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #aebd71 be deposited in the ,customs ,user ,fee ,account and shall be used to directly reimburse each appropriation for the amount paid out of that appropriation for the costs incurred in providing services to international mail facilities4 ,amounts deposited in accordance with the preceding sentence shall be available until expended for the provision of customs services to international mail facilities4 7ii7 ,notwithstanding section #ebd of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #aebd71 #ej percent of the amount of payments received under this paragraph shall be paid to the ,secretary of the ,treasury1 which is in lieu of the payment of fees under paragraph 7#aj74 4 7#b7 ,technical amendments ,paragraph 7#aj7 of section #acjca7;a7 of the ,consolidated ,omnibus ,budget ,reconciliation ,act of #aihe 7#ai ,u4,s4,c4 #eh;c7a77#aj77 is amended-- 7,a7 by striking or in subparagraph 7,b72 7,b7 by striking the period at the end of subparagraph 7,c77iii7 and inserting a comma and or2 7,c7 by inserting after subparagraph 7,c77iii7 the following3 7,d7 an international mail facility4 2 and 7,d7 in the undesignated material at the end by striking the period and inserting or referred to in subparagraph 7,d7 see paragraph 7#f744 7e7 ,mandatory advanced electronic information for postal shipments ,subparagraph 7,k7 of section #cdc7;a77#c7 of the ,trade ,act of #bjjb 7,public ,law #ajg-baj2 #ai ,u4,s4,c4 #bjga note7 is amended to read as follows3 7,k7 ,the ,secretary shall require the ,postmaster ,general to transmit or to ensure the transmission of the information required in paragraphs 7#a7 and 7#b7 to ,u4,s4 ,customs and ,border ,protection for all shipments by the ,united ,states ,postal ,service which includes shipments that the ,united ,states ,postal ,service receives from foreign postal operators 7shipments from foreign postal operators may be transported by private carriers74 ,all regulations issued pursuant to this provision are required to impose the same information requirements on the ,united ,states ,postal ,service and private carriers4 4 7f7 ,manifest penalties applied to the ,united ,states ,postal ,service 7#a7 ,penalties for violations of the arrival1 reporting1 entry1 and clearance requirements ,section #dcf of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #adcf7 is amended by adding at the end the following new subsection3 7e7 ,civil penalties arising from violations for postal shipments ,with respect to civil penalties provided for in subsections 7b7 and 7d71 the ,postmaster ,general shall be liable for the penalty if the violation was caused by a foreign postal operator or the ,united ,states ,postal ,service4 4 7#b7 ,penalties for falsity or lack of manifest ,section #ehd of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #aehd7 is amended by adding at the end the following new subsection3 7c7 ,person directly or indirectly responsible shall include the ,postmaster ,general ,for purposes of subsection 7a71 the ,postmaster ,general may be the person directly or indirectly responsible for a discrepancy if the discrepancy is the result of-- 7#a7 an omission by a foreign postal operator or the ,united ,states ,postal ,service2 or 7#b7 false information regarding the shipment that was provided to the carrier by a foreign postal operator or the ,united ,states ,postal ,service4 4 7g7 ,limitation on international postal arrangements 7#a7 ,existing agreements 7,a7 ,in general ,in the event that any provision in this section is found to be in violation of obligations of the ,united ,states under the ,universal ,postal ,union1 the ,secretary of ,state shall negotiate to amend the relevant provisions of the agreement so that the ,united ,states is no longer in violation of the agreement4 7,b7 ,construction ,nothing in this subsection may be construed to require or permit any delay in the implementation of this section4 7#b7 ,future agreements ,the ,secretary of ,state may not conclude any international postal arrangement pursuant to the authority set out in section #djg of title #ci1 ,united ,states ,code1 that is inconsistent with this section or any amendment made by this section4 7h7 ,application of other customs laws 7#a7 ,in general ,u4,s4 ,customs and ,border ,protection shall ensure that all merchandise1 as that term is defined in subsection 7c7 of section #dih of the ,tariff ,act of #aicj 7#ai ,u4,s4,c4 #adih71 imported to the ,united ,states through the mail shall be subject to the same import procedures1 legal restrictions1 and certifications as merchandise imported by private carriers4 7#b7 ,regulations ,the ,secretary of the ,treasury shall issue regulations pursuant to this section to ensure that merchandise imported through the mail is in accordance with ,federal law4 7i7 ,cost recoupment ,the ,postmaster ,general shall ensure that all costs associated with complying with this section1 as well as all penalties assessed against the ,postmaster ,general1 are charged directly to foreign shippers1 foreign postal operators1 or ,united ,states ultimate consignees4 7j7 ,effective date2 regulations 7#a7 ,effective date ,this section shall become effective upon the date of the enactment of this ,act4 7#b7 ,regulations ,not later than #a year after the date of the enactment of this ,act1 the ,secretary shall prescribe all regulations required under this section4 #h4 ,stop the ,importation and ,trafficking of ,synthetic ,analogues 7a7 ,establishment of ,schedule ,a ,section #bjb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hab7 is amended-- 7#a7 in subsection 7a71 by striking five schedules of controlled substances1 to be known as schedules ,i1 ,,ii1 ,,iii1 ,,iv1 and ,v and inserting six schedules of controlled substances1 to be known as schedules ,i1 ,,ii1 ,,iii1 ,,iv1 ,v1 and ,a2 7#b7 in subsection 7b71 by adding at the end the following3 7#f7 ,schedule ,a 7,a7 ,in general ,the drug or substance-- 7i7 has-- 7,i7 a chemical structure that is substantially similar to the chemical structure of a controlled substance in schedule ,i1 ,,ii1 ,,iii1 ,,iv1 or ,v2 and 7,,ii7 an actual or predicted stimulant1 depressant1 or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant1 depressant1 or hallucinogenic effect on the central nervous system of a controlled substance in schedule ,i1 ,,ii1 ,,iii1 ,,iv1 or ,v2 and 7ii7 is not-- 7,i7 listed or otherwise included in any other schedule in this section or by regulation of the ,attorney ,general2 and 7,,ii7 with respect to a particular person1 subject to an exemption that is in effect for investigational use1 for that person1 under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 to the extent conduct with respect to such substance is pursuant to such exemption4 7,b7 ,predicted stimulant1 depressant1 or hallucinogenic effect ,for purpose of this paragraph1 a predicted stimulant1 depressant1 or hallucinogenic effect on the central nervous system may be based on-- 7i7 the chemical structure1 structure activity relationships1 binding receptor assays1 or other relevant scientific information about the substance2 7ii7 7,i7 the current or relative potential for abuse of the substance2 and 7,,ii7 the clandestine importation1 manufacture1 or distribution1 or diversion from legitimate channels1 of the substance2 or 7iii7 the capacity of the substance to cause a state of dependence1 including physical or psychological dependence that is similar to or greater than that of a controlled substance in schedule ,i1 ,,ii1 ,,iii1 ,,iv1 or ,v4 2 and 7#c7 in subsection 7c7-- 7,a7 in the matter preceding schedule ,i1 by striking ,,iv1 and ,v and inserting ,,iv1 ,v1 and ,a2 and 7,b7 by adding at the end the following3 ,schedule ,a 7a7 ,unless specifically excepted or unless listed in another schedule1 any of the following substances1 as scheduled in accordance with section #bja7k77#e73 7#a7 #d-;fluoroisobutyryl fentanyl4 7#b7 ,valeryl fentanyl4 7#c7 #d-methoxybutyryl fentanyl4 7#d7 #d-methylphenethyl acetyl fentanyl4 7#e7 #c-;furanyl fentanyl4 7#f7 ,ortho-fluorofentanyl4 7#g7 ,tetrahydrofuranyl fentanyl4 7#h7 ,ocfentanil4 7#i7 #d-;fluorobutyryl fentanyl4 7#aj7 ,methoxyacetyl fentanyl4 7#aa7 ,meta-fluorofentanyl4 7#ab7 ,isobutyryl fentanyl4 7#ac7 ,acryl fentanyl4 4 7b7 ,temporary and permanent scheduling of schedule ,a substances ,section #bja of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #haa7 is amended by adding at the end the following3 7k7 ,temporary and permanent scheduling of schedule ,a substances 7#a7 ,the ,attorney ,general may issue a temporary order adding a drug or substance to schedule ,a if the ,attorney ,general finds that-- 7,a7 the drug or other substance satisfies the criteria for being considered a schedule ,a substance2 and 7,b7 adding such drug or substance to schedule ,a will assist in preventing abuse or misuse of the drug or other substance4 7#b7 ,a temporary scheduling order issued under paragraph 7#a7 shall not take effect until #cj days after the date of the publication by the ,attorney ,general of a notice in the ,federal ,register of the intention to issue such order and the grounds upon which such order is to be issued4 ,the temporary scheduling order shall expire not later than #e years after the date it becomes effective1 except that the ,attorney ,general may1 during the pendency of proceedings under paragraph 7#e71 extend the temporary scheduling order for up to #ahj days4 7#c7 ,a temporary scheduling order issued under paragraph 7#a7 shall be vacated upon the issuance of a permanent order issued under paragraph 7#e7 with regard to the same substance1 or upon the subsequent issuance of any scheduling order under this section4 7#d7 ,a temporary scheduling order issued under paragraph 7#a7 shall not be subject to judicial review4 7#e7 ,the ,attorney ,general may1 by rule1 issue a permanent order adding a drug or other substance to schedule ,a if such drug or substance satisfies the criteria for being considered a schedule ,a substance4 ,such rulemaking may be commenced simultaneously with the issuance of the temporary scheduling order issued under paragraph 7#a7 with regard to the same substance4 7#f7 ,before initiating proceedings under paragraph 7#a7 or 7#e71 the ,attorney ,general shall transmit notice of an order proposed to be issued to the ,secretary of ,health and ,human ,services4 ,in issuing an order under paragraph 7#a7 or 7#e71 the ,attorney ,general shall take into consideration any comments submitted by the ,secretary of ,health and ,human ,services in response to a notice transmitted pursuant to this paragraph4 7#g7 ,on the date of the publication of a notice in the ,federal ,register pursuant to paragraph 7#b71 the ,attorney ,general shall transmit the same notice to ,congress4 ,the temporary scheduling order shall take effect according to paragraph 7#b71 except that the temporary scheduling order may be disapproved by ,act of ,congress within #ahj days from the date of publication of the notice in the ,federal ,register4 4 7c7 ,penalties 7#a7 ,controlled ,substances ,act ,the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq47 is amended-- 7,a7 in section #dja7;b77#a7 7#ba ,u4,s4,c4 #hda7;b77#a771 by adding at the end the following3 7,f7 7i7 ,in the case of any controlled substance in schedule ,a1 such person shall be sentenced to a term of imprisonment of not more than #aj years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not more than #ae years1 a fine not to exceed the greater of that authorized in accordance with the provisions of title #ah1 ,united ,states ,code1 or #ejj1jjj if the defendant is an individual or #b1ejj1jjj if the defendant is other than an individual1 or both4 7ii7 ,if any person commits such a violation after a prior conviction for a felony drug offense has become final1 such person shall be sentenced to a term of imprisonment of not more than #bj years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not more than #cj years1 a fine not to exceed the greater of twice that authorized in accordance with the provisions of title #ah1 ,united ,states ,code1 or #a1jjj1jjj if the defendant is an individual or #e1jjj1jjj if the defendant is other than an individual1 or both4 7iii7 ,any sentence imposing a term of imprisonment under this subparagraph shall1 in the absence of such a prior conviction1 impose a term of supervised release of not less than #b years in addition to such term of imprisonment and shall1 if there was such a prior conviction1 impose a term of supervised release of not less than #d years in addition to such term of imprisonment4 2 7,b7 in section #djc7;a7 7#ba ,u4,s4,c4 #hdc7;a77-- 7i7 in paragraph 7#h71 by striking or at the end2 7ii7 in paragraph 7#i71 by striking the period at the end and inserting 2 or2 and 7iii7 by inserting after paragraph 7#i7 the following3 7#aj7 to export a substance in violation of the controlled substance laws of the country to which the substance is exported4 2 and 7,c7 in section #djd 7#ba ,u4,s4,c4 #hdd71 by inserting after subsection 7a7 the following3 7b7 ,a person shall not be subject to a criminal or civil penalty under this title or under any other ,federal law solely for possession of a schedule ,a controlled substance4 4 7#b7 ,controlled ,substances ,import and ,export ,act ,section #ajaj7;b7 of the ,controlled ,substances ,import and ,export ,act 7#ba ,u4,s4,c4 #ifj7;b77 is amended by adding at the end the following3 7#h7 ,in the case of a violation under subsection 7a7 involving a controlled substance in schedule ,a1 the person committing such violation shall be sentenced to a term of imprisonment of not more than #bj years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not more than life1 a fine not to exceed the greater of that authorized in accordance with the provisions of title #ah1 ,united ,states ,code1 or #a1jjj1jjj if the defendant is an individual or #e1jjj1jjj if the defendant is other than an individual1 or both4 ,if any person commits such a violation after a prior conviction for a felony drug offense has become final1 such person shall be sentenced to a term of imprisonment of not more than #cj years and if death or serious bodily injury results from the use of such substance shall be sentenced to not more than life imprisonment1 a fine not to exceed the greater of twice that authorized in accordance with the provisions of title #ah1 ,united ,states ,code1 or #b1jjj1jjj if the defendant is an individual or #aj1jjj1jjj if the defendant is other than an individual1 or both4 ,notwithstanding section #cehc of title #ah1 ,united ,states ,code1 any sentence imposing a term of imprisonment under this paragraph shall1 in the absence of such a prior conviction1 impose a term of supervised release of not less than #c years in addition to such term of imprisonment and shall1 if there was such a prior conviction1 impose a term of supervised release of not less than #f years in addition to such term of imprisonment4 ,notwithstanding the prior sentence1 and notwithstanding any other provision of law1 the court shall not place on probation or suspend the sentence of any person sentenced under the provisions of this paragraph which provide for a mandatory term of imprisonment if death or serious bodily injury results4 4 7d7 ,false labeling of schedule ,a controlled substances 7#a7 ,in general ,section #cje of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbe7 is amended by adding at the end the following3 7f7 ,false labeling of schedule ,a controlled substances 7#a7 ,it shall be unlawful to import1 export1 manufacture1 distribute1 dispense1 or possess with intent to manufacture1 distribute1 or dispense1 a schedule ,a substance or product containing a schedule ,a substance1 unless the substance or product bears a label clearly identifying a schedule ,a substance or product containing a schedule ,a substance by the nomenclature used by the ,international ,union of ,pure and ,applied ,chemistry 7,,iupac74 7#b7 7,a7 ,a product described in subparagraph 7,b7 is exempt from the ,international ,union of ,pure and ,applied ,chemistry nomenclature requirement of this subsection if such product is labeled in the manner required under the ,federal ,food1 ,drug1 and ,cosmetic ,act4 7,b7 ,a product is described in this subparagraph if the product-- 7i7 is the subject of an approved application as described in section #eje7;b7 or 7j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act2 or 7ii7 is exempt from the provisions of section #eje of such ,act relating to new drugs because-- 7,i7 it is intended solely for investigational use as described in section #eje7;i7 of such ,act2 and 7,,ii7 such product is being used exclusively for purposes of a clinical trial that is the subject of an effective investigational new drug application4 4 7#b7 ,penalties ,section #djb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hdb7 is amended-- 7,a7 in subsection 7a77#af71 by inserting or subsection 7f7 after subsection 7e72 and 7,b7 in subsection 7c77#a77;,d71 by inserting or a schedule ,a substance after anabolic steroid4 7e7 ,registration requirements for handlers of schedule ,a substances 7#a7 ,controlled ,substances ,act ,section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7 is amended by adding at the end the following3 7k7 7#a7 ,the ,attorney ,general shall register an applicant to manufacture schedule ,a substances if-- 7,a7 the applicant demonstrates that the schedule ,a substances will be used for research1 analytical1 or industrial purposes approved by the ,attorney ,general2 and 7,b7 the ,attorney ,general determines that such registration is consistent with the public interest and with the ,united ,states obligations under international treaties1 conventions1 or protocols in effect on the date of enactment of this subsection4 7#b7 ,in determining the public interest under paragraph 7#a77;,b71 the ,attorney ,general shall consider-- 7,a7 maintenance of effective controls against diversion of particular controlled substances and any controlled substance in schedule ,a compounded therefrom into other than legitimate medical1 scientific1 research1 or industrial channels1 by limiting the importation and bulk manufacture of such controlled substances to a number of establishments which can produce an adequate and uninterrupted supply of these substances under adequately competitive conditions for legitimate medical1 scientific1 research1 and industrial purposes2 7,b7 compliance with applicable ,state and local law2 7,c7 promotion of technical advances in the art of manufacturing substances described in subparagraph 7,a7 and the development of new substances2 7,d7 prior conviction record of applicant under ,federal and ,state laws relating to the manufacture1 distribution1 or dispensing of substances described in paragraph 7,a72 7,e7 past experience in the manufacture of controlled substances1 and the existence in the establishment of effective control against diversion2 and 7,f7 such other factors as may be relevant to and consistent with the public health and safety4 7#c7 ,if an applicant is registered to manufacture controlled substances in schedule ,i or ,,ii under subsection 7a71 the applicant shall not be required to apply for a separate registration under this subsection4 7l7 7#a7 ,the ,attorney ,general shall register an applicant to distribute schedule ,a substances-- 7,a7 if the applicant demonstrates that the schedule ,a substances will be used for research1 analytical1 or industrial purposes approved by the ,attorney ,general2 and 7,b7 unless the ,attorney ,general determines that the issuance of such registration is inconsistent with the public interest4 7#b7 ,in determining the public interest under paragraph 7#a77;,b71 the ,attorney ,general shall consider-- 7,a7 maintenance of effective control against diversion of particular controlled substances into other than legitimate medical1 scientific1 and industrial channels2 7,b7 compliance with applicable ,state and local law2 7,c7 prior conviction record of applicant under ,federal or ,state laws relating to the manufacture1 distribution1 or dispensing of substances described in subparagraph 7,a72 7,d7 past experience in the distribution of controlled substances2 and 7,e7 such other factors as may be relevant to and consistent with the public health and safety4 7#c7 ,if an applicant is registered to distribute a controlled substance in schedule ,i or ,,ii under subsection 7b71 the applicant shall not be required to apply for a separate registration under this subsection4 7m7 7#a7 ,not later than #ij days after the date on which a substance is placed in schedule ,a1 any practitioner who was engaged in research on the substance before the placement of the substance in schedule ,a and any manufacturer or distributor who was handling the substance before the placement of the substance in schedule ,a shall register with the ,attorney ,general4 7#b7 7,a7 ,not later than #fj days after the date on which the ,attorney ,general receives an application for registration to conduct research on a schedule ,a substance1 the ,attorney ,general shall-- 7i7 grant1 or initiate proceedings under section #cjd7;c7 to deny1 the application2 or 7ii7 request supplemental information from the applicant4 7,b7 ,not later than #cj days after the date on which the ,attorney ,general receives supplemental information requested under subparagraph 7,a77ii7 in connection with an application described in subparagraph 7,a71 the ,attorney ,general shall grant or deny the application4 7n7 7#a7 ,the ,attorney ,general shall register a scientific investigator or a qualified research institution to conduct research with controlled substances in schedule ,a in accordance with this subsection4 ,in evaluating applications for such registration1 the ,attorney ,general shall apply the criteria set forth in subsection 7f7 of this section that apply to practitioners seeking a registration to conduct research with a schedule ,i controlled substance1 except that the applicant shall not be required to submit a research protocol4 7#b7 ,if the applicant is not currently registered under subsection 7f7 to conduct research with a schedule ,i controlled substance1 the ,attorney ,general shall refer the application to the ,secretary1 who shall determine whether the applicant will be engaged in bona fide research and is qualified to conduct such research4 7#c7 ,if the applicant is currently registered under subsection 7f7 to conduct research with a schedule ,i controlled substance1 the applicant will be considered qualified to conduct research with controlled substances in schedule ,a and the ,attorney ,general shall modify the applicant's registration to include schedule ,a controlled substances in accordance with this paragraph4 ,the applicant shall notify the ,attorney ,general of his intent to conduct research with a controlled substance in schedule ,a4 ,upon receiving such notification1 the ,attorney ,general shall modify the practitioner's existing registration to authorize research with schedule ,a controlled substances1 unless the ,attorney ,general determines that the registration modification would be inconsistent with the public interest based on the criteria of subsection 7f74 7#d7 ,registrations issued under this subsection to a qualified research institution will apply to all agents and employees of that institution acting within the scope of their professional practice4 7#e7 ,at least thirty days prior to conducting any research with a controlled substance in schedule ,a1 the registrant shall provide the ,attorney ,general with written notification of the following3 7,a7 ,the name of and drug code for each substance4 7,b7 ,the name of each individual with access to each substance4 7,c7 ,the amount of each substance4 7,d7 ,other similar information the ,attorney ,general may require4 7#f7 ,the quantity of a schedule ,a controlled substance possessed by a person registered under this subsection shall be appropriate for the research being conducted1 subject to the additional limitations set forth in this paragraph4 ,to reduce the risk of diversion1 the ,attorney ,general may establish limitations on the quantity of schedule ,a controlled substances that may be manufactured or possessed for purposes of research under this subsection and shall publish such limitations on the website of the ,drug ,enforcement ,administration4 ,a person registered under this subsection may1 based on legitimate research needs1 apply to the ,attorney ,general to manufacture or possess an amount greater than that so specified by the ,attorney ,general4 ,the ,attorney ,general shall specify the manner in which such applications shall be submitted4 ,the ,attorney ,general shall act on an application filed under this subparagraph within #cj days of receipt of such application4 ,if the ,attorney ,general fails to act within #cj days1 the registrant shall be allowed to manufacture and possess up to the amount requested4 ,the ,attorney ,general shall have the authority to reverse the increase for cause4 7#g7 ,the ,attorney ,general shall by regulation specify the manner in which applications for registration under this subsection shall be submitted4 7#h7 ,registrants authorized under this subsection may manufacture and possess schedule ,a controlled substances up to the approved amounts only for use in their own research setting or institution4 ,manufacturing for use in any other setting or institution shall require a manufacturer's registration under section #cjc7;a74 4 7#b7 ,controlled ,substances ,import and ,export ,act ,section #ajjh of the ,controlled ,substances ,import and ,export ,act 7#ba ,u4,s4,c4 #ieh7 is amended by adding at the end the following3 7j7 7#a7 ,the ,attorney ,general shall register an applicant to import or export a schedule ,a substance if-- 7,a7 the applicant demonstrates that the schedule ,a substances will be used for research1 analytical1 or industrial purposes approved by the ,attorney ,general2 and 7,b7 the ,attorney ,general determines that such registration is consistent with the public interest and with the ,united ,states obligations under international treaties1 conventions1 or protocols in effect on the date of enactment of this subsection4 7#b7 ,in determining the public interest under paragraph 7#a77;,b71 the ,attorney ,general shall consider the factors described in subparagraphs 7,a7 through 7,f7 of section #cjc7k77#b74 7#c7 ,if an applicant is registered to import or export a controlled substance in schedule ,i or ,,ii under subsection 7a71 the applicant shall not be required to apply for a separate registration under this subsection4 4 7f7 ,additional conforming amendments 7#a7 ,controlled ,substances ,act ,the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq47 is amended-- 7,a7 in section #cjc7;c7 7#ba ,u4,s4,c4 #hbc7;c77-- 7i7 by striking subsections 7a7 and 7b7 and inserting subsection 7a71 7b71 7k71 or 7l72 and 7ii7 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7,b7 in section #cjf 7#ba ,u4,s4,c4 #hbf7-- 7i7 in subsection 7a71 in the first sentence1 by striking schedules ,i and ,,ii and inserting schedules ,i1 ,,ii1 and ,a2 7ii7 in subsection 7b71 in the second sentence1 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7iii7 in subsection 7c71 in the first sentence1 by striking schedules ,i and ,,ii and inserting schedules ,i1 ,,ii1 and ,a2 7iv7 in subsection 7d71 in the first sentence1 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7v7 in subsection 7e71 in the first sentence1 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7vi7 in subsection 7f71 in the first sentence1 by striking schedules ,i and ,,ii and inserting schedules ,i1 ,,ii1 and ,a2 7,c7 in section #cjh7;a7 7#ba ,u4,s4,c4 #hbh7;a771 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7,d7 in section #djb7;b7 7#ba ,u4,s4,c4 #hdb7;b771 in the matter preceding paragraph 7#a71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7,e7 in section #djc7;a77#a7 7#ba ,u4,s4,c4 #hdc7;a77#a771 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7,f7 in section #eaa7;f7 7#ba ,u4,s4,c4 #hha7;f771 by striking schedule ,i or ,,ii each place it appears and inserting schedule ,i1 ,,ii1 or ,a4 7#b7 ,controlled ,substances ,import ,export ,act ,the ,controlled ,substances ,import and ,export ,act 7#ba ,u4,s4,c4 #iea et seq47 is amended-- 7,a7 in section #ajjb7;a7 7#ba ,u4,s4,c4 #ieb7;a77-- 7i7 in the matter preceding paragraph 7#a71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7ii7 in paragraph 7#b71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7,b7 in section #ajjc 7#ba ,u4,s4,c4 #iec7-- 7i7 in subsection 7c71 in the matter preceding paragraph 7#a71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7ii7 in subsection 7d71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 7,c7 in section #ajjd7a7 7#ba ,u4,s4,c4 #ied7a771 by striking schedule ,i and inserting schedule ,i or ,a2 7,d7 in section #ajje 7#ba ,u4,s4,c4 #iee71 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a2 and 7,e7 in section #ajji7;a7 7#ba ,u4,s4,c4 #iei7;a771 by striking schedule ,i or ,,ii and inserting schedule ,i1 ,,ii1 or ,a4 7g7 ,controlled substance analogues ,section #ajb of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hjb7 is amended-- 7#a7 in paragraph 7#f71 by striking or ,v and inserting ,v1 or ,a2 7#b7 in paragraph 7#ad7-- 7,a7 by striking schedule ,i7c7 and and inserting schedule ,i7c71 schedule ,a1 and2 and 7,b7 by striking schedule ,i7c71 and inserting schedule ,i7c7 and schedule ,a12 and 7#c7 in paragraph 7#cb77;,a71 by striking 7#cb77;,a7 and all that follows through clause 7iii7 and inserting the following3 7#cb7 7,a7 ,except as provided in subparagraph 7,c71 the term controlled substance analogue means a substance whose chemical structure is substantially similar to the chemical structure of a controlled substance in schedule ,i or ,,ii-- 7i7 which has a stimulant1 depressant1 or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant1 depressant1 or hallucinogenic effect on the central nervous system of a controlled substance in schedule ,i or ,,ii2 or 7ii7 with respect to a particular person1 which such person represents or intends to have a stimulant1 depressant1 or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant1 depressant1 or hallucinogenic effect on the central nervous system of a controlled substance in schedule ,i or ,,ii4 4 7h7 ,amendment to the sentencing guidelines ,section #b;,d#a4a of the ,federal ,sentencing ,guidelines is amended1 in ,application ,note #f 7,analogues and ,controlled ,substances ,not ,referenced in this ,guideline7 of the ,commentary1 by striking ,in determining the most closely related controlled substance1 the court shall1 to the extent practicable1 consider the following3 and inserting the following3 ,in determining the most closely related controlled substance and the applicable guideline or drug equivalence1 the court shall-- 7,a7 if ,attorney ,general has provided guidance on the appropriate sentencing equivalency or ratio to a controlled substance that is referenced in the guidelines through publication in the ,federal ,register 7whether such guidance is included in or separate from any notice of proposed temporary or permanent scheduling of such substance under section #bja of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #haa771 apply any such sentencing equivalency or ratio2 and 7,b7 in the absence of guidance with respect to a substance or group of substances as described in paragraph 7,a71 use equivalencies for the following structural classes of substances as if they were included on the ,drug ,equivalency ,tables3 ,drug ,class,marihuana ,equivalency of #a gm of subject substance,synthetic ,opioids#a gm #aj kg,synthetic ,cannabinoids#a gm #afg gm,synthetic ,cathinones#a gm #chj gm,tryptamine#a gm #hj gm,phenethylamines#a gm #b4e kg,piperazines#a gm #b kg,benzofurans#a gm #ejj gm,arylcyclohexylamines 7,,pcp-like substances7#a gm #a kg,methylphenidate analogs#a gm #ajj gm,benzodiazepines#a unit 7as defined in ,note 7,f7 to the ,drug ,quantity ,table in #b;,d#a4a7 #j4jfbe gm ,in the case of a substance for which paragraphs 7,a7 and 7,b7 above are not applicable1 the court shall determine an equivalency or ratio by considering the following factors1 to the extent practicable3 4 7i7 ,rules of construction ,nothing in this section1 or the amendments made by this section1 may be construed to limit-- 7#a7 the prosecution of offenses involving controlled substance analogues under the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hja et seq472 or 7#b7 the authority of the ,attorney ,general to temporarily or permanently schedule1 reschedule1 or decontrol controlled substances under provisions of section #bja of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #haa7 that are in effect on the day before the date of enactment of this ,act4 7j7 ,study by ,comptroller ,general ,not later than #b years after the date of enactment of this ,act1 the ,comptroller ,general of the ,united ,states shall complete a study and submit a report to the ,committees on the ,judiciary of the ,house of ,representatives and of the ,senate regarding the costs associated with the amendments made by subsection 7c71 including-- 7#a7 the annual amounts expended by ,federal agencies in carrying out the amendments2 7#b7 the costs associated with arrests1 trials1 convictions1 imprisonment1 or imposition of other sanctions in accordance with the amendments2 and 7#c7 the impact 7including the fiscal impact7 of the amendments on existing correctional facilities and the likelihood that those amendments will create a need for additional capacity for housing prisoners4